Menu
GWAS Study

Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine program.

Armstrong ND, Srinivasasainagendra V, Ammous F et al.

38162683 PubMed ID
GWAS Study Type
7129 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AN
Armstrong ND
SV
Srinivasasainagendra V
AF
Ammous F
AT
Assimes TL
BA
Beitelshees AL
BJ
Brody J
CB
Cade BE
IC
Ida Chen YD
CH
Chen H
DV
de Vries PS
FJ
Floyd JS
FN
Franceschini N
GX
Guo X
HJ
Hellwege JN
HJ
House JS
HC
Hwu CM
KS
Kardia SLR
LE
Lange EM
LL
Lange LA
MC
McDonough CW
MM
Montasser ME
OJ
O'Connell JR
SM
Shuey MM
SX
Sun X
TR
Tanner RM
WZ
Wang Z
ZW
Zhao W
CA
Carson AP
ET
Edwards TL
KT
Kelly TN
KE
Kenny EE
KC
Kooperberg C
LR
Loos RJF
MA
Morrison AC
MA
Motsinger-Reif A
PB
Psaty BM
RD
Rao DC
RS
Redline S
RS
Rich SS
RJ
Rotter JI
SJ
Smith JA
SA
Smith AV
IM
Irvin MR
AD
Arnett DK
Chapter II

Abstract

Summary of the research findings

Introduction: Apparent treatment-resistant hypertension (aTRH) is characterized by the use of four or more antihypertensive (AHT) classes to achieve blood pressure (BP) control. In the current study, we conducted single-variant and gene-based analyses of aTRH among individuals from 12 Trans-Omics for Precision Medicine cohorts with whole-genome sequencing data. Methods: Cases were defined as individuals treated for hypertension (HTN) taking three different AHT classes, with average systolic BP ≥ 140 or diastolic BP ≥ 90 mmHg, or four or more medications regardless of BP (n = 1,705). A normotensive control group was defined as individuals with BP < 140/90 mmHg (n = 22,079), not on AHT medication. A second control group comprised individuals who were treatment responsive on one AHT medication with BP < 140/ 90 mmHg (n = 5,424). Logistic regression with kinship adjustment using the Scalable and Accurate Implementation of Generalized mixed models (SAIGE) was performed, adjusting for age, sex, and genetic ancestry. We assessed variants using SKAT-O in rare-variant analyses. Single-variant and gene-based tests were conducted in a pooled multi-ethnicity stratum, as well as self-reported ethnic/racial strata (European and African American). Results: One variant in the known HTN locus, KCNK3, was a top finding in the multi-ethnic analysis (p = 8.23E-07) for the normotensive control group [rs12476527, odds ratio (95% confidence interval) = 0.80 (0.74-0.88)]. This variant was replicated in the Vanderbilt University Medical Center's DNA repository data. Aggregate gene-based signals included the genes AGTPBP, MYL4, PDCD4, BBS9, ERG, and IER3. Discussion: Additional work validating these loci in larger, more diverse populations, is warranted to determine whether these regions influence the pathobiology of aTRH.

768 African American or Afro-Caribbean cases, 1,924 African American or Afro-Caribbean controls, 395 European ancestry cases, 2,730 European ancestry controls, 51 East Asian ancestry cases, 236 East Asian ancestry controls, 448 Hispanic or Latin American cases, 477 Hispanic or Latin American controls, 43 Other ancestry cases, 57 Other ancestry controls

Chapter III

Study Statistics

Key metrics and study information

7129
Total Participants
GWAS
Study Type
No
Replicated
African American or Afro-Caribbean, European, East Asian, Hispanic or Latin American, Other
Ancestry
U.S., China, Taiwan
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.